EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Field‐Deployable RotEx‐LAMP‐LFA Platform for Molecular Triage of HPV‐Driven Oncogenesis

Yuan Gao, Qiang Wen, Siyuan Qiao, Linyi Deng, Keyue Li, Zhuyan Shao, Xiaonan Liu, Tao Zhu, Chao Zhang, Da Han iD, Weihong Tan

Advanced Science · 2025-12 · 12 (47)

DOI: 10.1002/advs.202509468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.09.2025. Verfasst von Yuan Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Nucleic Acid Amplification Techniques, Uterine Cervical Neoplasms, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Raising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persisting as a major global health disparity, HPV16/18‐associated cervical carcinogenesis continues to disproportionately affect populations in resource‐limited regions with compromised screening infrastructure. While molecular detection of E6/E7 oncogenic transcripts surpasses conventional cytology in clinical specificity, current nucleic acid amplification platforms remain impeded by technical complexity, prolonged turnaround times (>4 h), and substantial per‐test costs (>$50) that hinder scale‐up in low‐income settings. Here, RotEx‐LAMP‐LFA is presented: an innovative point‐of‐care system integrating microfluidic nucleic acid extraction, rapid isothermal amplification (30 min at 63 °C), and combined lateral flow detection in a single disposable cartridge. Validated with 69 clinical specimens (19 histology‐confirmed SCC, 14 HPV+ precancerous lesions, 15 HPV+ infections, and 21 healthy controls), this sample‐to‐answer platform achieved 94.74% sensitivity (18/19; 95% CI: 84.72–100%) for invasive carcinoma detection with 100% (36/36; 95% CI: 90.44‐99.93%) specificity for non‐cancer. In addition, a subset of samples is collected through paired self‐sampling to validate consistency with clinician‐collected specimens, indicating that this innovative platform shows promise for community‐level molecular stratification of persistent and progressive HPV infections. It paves the way for accessible, patient‐centered cervical cancer risk reporting, with the potential to reduce psychological burden on patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsNucleic Acid Amplification TechniquesUterine Cervical NeoplasmsMolecular Diagnostic TechniquesCarcinogenesisHumansFemaleSensitivity and SpecificityTriageHuman papillomavirus 16

Stichwörter der Autor:innen

LAMP‐LFAcervical cancerdiagnostic deviceshuman papillomaviruspoint‐of‐care testing

Autor:innen und Institutionen

  • Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
  • Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
  • School of Forensic Medicine, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Provi…

ORCID-Profile: Da Han

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Raising-Star Program
  • Shanghai Municipal Health Commission Clinical Research Program
  • Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine "Clinic Plus" Outstanding Project
  • Key R&D Program of Zhejiang

Zitieren

APA

Gao, Y., Wen, Q., Qiao, S., Deng, L., Li, K., Shao, Z., Liu, X., Zhu, T., Zhang, C., Han, D., & Tan, W. (2025). A Field‐Deployable RotEx‐LAMP‐LFA Platform for Molecular Triage of HPV‐Driven Oncogenesis. Advanced Science, 12(47). https://doi.org/10.1002/advs.202509468

Vancouver

Gao Y, Wen Q, Qiao S, Deng L, Li K, Shao Z, et al. A Field‐Deployable RotEx‐LAMP‐LFA Platform for Molecular Triage of HPV‐Driven Oncogenesis. Advanced Science. 2025;12(47). doi:10.1002/advs.202509468

BibTeX
@article{Gao2025,
  author = {Gao, Yuan and Wen, Qiang and Qiao, Siyuan and Deng, Linyi and Li, Keyue and Shao, Zhuyan and Liu, Xiaonan and Zhu, Tao and Zhang, Chao and Han, Da and Tan, Weihong},
  title = {A Field‐Deployable RotEx‐LAMP‐LFA Platform for Molecular Triage of HPV‐Driven Oncogenesis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {47},
  doi = {10.1002/advs.202509468}
}
Kostenlos starten →